Display options
Share it on

Front Aging Neurosci. 2018 Sep 26;10:288. doi: 10.3389/fnagi.2018.00288. eCollection 2018.

Enriched Environment Significantly Reduced Senile Plaques in a Transgenic Mice Model of Alzheimer's Disease, Improving Memory.

Frontiers in aging neuroscience

Janaina Balthazar, Natalia Mendes Schöwe, Gabriela Cabett Cipolli, Hudson Sousa Buck, Tania Araujo Viel

Affiliations

  1. Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  2. School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, Brazil.
  3. Department of Physiological Sciences, Faculdade de Ciências Médicas, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.

PMID: 30319394 PMCID: PMC6168651 DOI: 10.3389/fnagi.2018.00288

Abstract

Alzheimer's disease (AD) is associated with a progressive dementia, and there is good evidence that it is more pronounced in individuals that have fewer stimuli during their lives. Environmental stimulation promotes morphological and functional changes in the brain, leading to amplification of cognitive functions, and has been described in humans and animals. In this study, we evaluated the effects of enriched environment (EE) stimulation on spatial memory and senile plaque formation in transgenic mice PDGFB-APPSwInd (TG) that overexpress the human amyloid precursor protein, normally resulting in an increased density of senile plaques. We compared this group of EE stimulated transgenic mice (TG-EE) with an EE stimulated control group of age-matched C57Bl/6 wild type animals (WT-EE). Both groups were exposed to EE stimulation between the ages of 8 and 12 months. As controls of the experiment, there were a group of TG mice not exposed to EE (TG-Ctrl) and a group of WT mice not exposed to EE (WT-Ctrl). The TG-EE group presented improved spatial memory when compared to the TG-Ctrl animals. In addition, the TG-EE group showed a 69.2% reduction in the total density of senile plaques in the hippocampus when compared to the TG-Ctrl group. In this group, the concentration of senile plaques was greater in the dorsal part of the hippocampus, which is linked to spatial localization, and the reduction of this density after the submission to EE was as high as 85.1%. EE stimulation had no effect on the density of amyloid-β (Aβ) oligomers. However, amyloid scavenger receptor class B member 1 (SR-B1) density was significantly decreased in the TG-Ctrl mice, but not in the TG-EE mice, suggesting that cognitive stimulation had an effect on the formation of a cognitive reserve that could prevent the accumulation of senile plaques. It is suggested that the stimulation of old mice by EE for 4 months led to the formation of brain resilience that protected the brain from the deposition of senile plaques, one of the hallmarks of AD, leading to improvement in spatial memory.

Keywords: Alzheimer’s disease; SR-B1; amyloid-beta scavenger; brain resilience; enriched environment; senile plaques; spatial memory; transgenic mice

References

  1. Neuron. 2010 Jan 14;65(1):7-19 - PubMed
  2. JCI Insight. 2017 Sep 7;2(17):null - PubMed
  3. J Neurosci. 2013 Jun 5;33(23):9626-34 - PubMed
  4. J Neurosci. 2017 Jan 4;37(1):152-163 - PubMed
  5. Trends Cogn Sci. 2013 Oct;17(10):502-9 - PubMed
  6. EMBO Mol Med. 2016 Jun 01;8(6):595-608 - PubMed
  7. Neurology. 2018 Apr 10;90(15):695-703 - PubMed
  8. Physiol Rev. 2007 Jul;87(3):873-904 - PubMed
  9. Anal Biochem. 1986 Aug 1;156(2):341-7 - PubMed
  10. ACS Chem Neurosci. 2014 Dec 17;5(12):1238-45 - PubMed
  11. Mech Ageing Dev. 2016 Apr;155:10-21 - PubMed
  12. PLoS One. 2013 Jul 24;8(7):e69381 - PubMed
  13. Exp Gerontol. 2013 Aug;48(8):831-8 - PubMed
  14. Mol Psychiatry. 2009 May;14(5):469-86 - PubMed
  15. Neurology. 2013 Aug 13;81(7):650-7 - PubMed
  16. Curr Neuropharmacol. 2017;15(4):459-470 - PubMed
  17. PLoS Med. 2017 Mar 21;14(3):e1002259 - PubMed
  18. Drug Des Devel Ther. 2013 Dec 06;7:1471-8 - PubMed
  19. Int J Biochem Cell Biol. 2009 Jun;41(6):1261-8 - PubMed
  20. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33 - PubMed
  21. Brain Res. 2013 May 1;1508:63-72 - PubMed
  22. Restor Neurol Neurosci. 2014;32(5):675-87 - PubMed
  23. Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20816-21 - PubMed
  24. Nat Med. 2001 May;7(5):612-8 - PubMed
  25. Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12 - PubMed
  26. Curr Top Behav Neurosci. 2012;10:293-316 - PubMed
  27. Exp Neurol. 2015 Feb;264:121-6 - PubMed
  28. Curr Psychiatry Rep. 2016 Sep;18(9):85 - PubMed
  29. Behav Brain Res. 2001 Nov 1;125(1-2):141-9 - PubMed
  30. J Neurochem. 2012 Jan;120 Suppl 1:125-39 - PubMed
  31. Curr Med Chem. 2018 Feb 28;: - PubMed
  32. Hippocampus. 2012 Nov;22(11):2157-70 - PubMed
  33. Neuron. 1996 Sep;17(3):553-65 - PubMed
  34. Neurobiol Aging. 2015 Apr;36(4):1639-1652 - PubMed
  35. Oxid Med Cell Longev. 2017;2017:9175806 - PubMed
  36. Pharmacol Biochem Behav. 2013 Feb;103(4):693-700 - PubMed
  37. Neurotox Res. 2018 Oct;34(3):733-748 - PubMed
  38. Neurobiol Aging. 2008 Dec;29(12):1805-14 - PubMed
  39. Exp Neurol. 2013 Jan;239:28-37 - PubMed
  40. Neurobiol Dis. 2011 Jun;42(3):530-8 - PubMed
  41. Behav Neurosci. 2007 Apr;121(2):340-4 - PubMed
  42. Neurobiol Aging. 2013 Jan;34(1):263-74 - PubMed
  43. Psychopharmacology (Berl). 2014 Nov;231(22):4361-70 - PubMed
  44. Physiol Behav. 2015 Apr 1;142:131-6 - PubMed
  45. Cold Spring Harb Perspect Med. 2015 Sep 18;5(10):null - PubMed
  46. Alzheimers Dement (N Y). 2017 May 24;3(3):367-384 - PubMed
  47. PLoS One. 2015 Nov 25;10(11):e0142267 - PubMed
  48. Trends Neurosci. 2018 Jan;41(1):4-17 - PubMed
  49. Mol Neurobiol. 2017 Oct;54(8):6542-6555 - PubMed
  50. Science. 2012 Mar 9;335(6073):1228-31 - PubMed
  51. Nature. 2006 Mar 16;440(7082):352-7 - PubMed
  52. Neuroscience. 2008 Feb 6;151(3):745-9 - PubMed
  53. Exp Gerontol. 2015 Oct;70:11-7 - PubMed
  54. Alzheimers Dement. 2009 Jan;5(1):66-74 - PubMed
  55. Front Aging Neurosci. 2015 Aug 10;7:134 - PubMed
  56. Antioxid Redox Signal. 2011 Apr 15;14(8):1519-34 - PubMed
  57. Rev Neurosci. 2011;22(3):259-66 - PubMed
  58. PLoS Med. 2017 Mar 14;14(3):e1002251 - PubMed
  59. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):331-9 - PubMed

Publication Types